Clinical Development,Clinical Operations,News

Overcoming the Challenges of Decentralised Trials

3 months ago By Josh Neil
  • Share on

  • Facebook
  • Linkedin

Decentralised trials – clinical trials with virtual or online elements – have a huge number of advantages in the trial space. They are cheaper, faster, and allow for greater safety and recruitment of patients. But so far they have yet to see a positive uptake in big pharma companies, despite technology for virtual form-filling, wearable monitoring systems and online patient check-ins all existing and highly affordable for pharma companies.

To clarify the area for professionals who need to know, Proventa International created a White Paper on decentralised and virtual trials, looking at the innovations and trends shaping 2020, the technologies available to pharma companies, and the biggest challenges facing these new trials and how to overcome them. Below is just a sample of the full White Paper: to read the larger report, click here.

If you are unable to see the PDF below, please click here.

For more information on future events, including the upcoming Clinical OperationsCTSC and Pharmacovigilance meetings in November 2020, click here.

Joshua Neil, Editor
Proventa International

More news

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

2 months ago
Clinical Development,Clinical Operations,News

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

2 months ago

Better CMC Organisation in Small Pharma Drug Development

Chemistry, Manufacturing and Controls (CMC) is a vital part of the drug development process. A CMC strategy gives companies a template for bringing a drug through the early clinical stages all the way to commercial manufacturing.  The CMC process has...

2 months ago
Clinical Development,Clinical Operations,News

Better CMC Organisation in Small Pharma Drug Development

Chemistry, Manufacturing and Controls (CMC) is a vital part of the drug development process. A CMC strategy gives companies a template for bringing a drug through the early clinical stages all the way to commercial manufacturing.  The CMC process has...

2 months ago

Solving Regulatory Issues in Cell and Gene Therapies

Cell and Gene Therapies (CGTs), experimental technologies to treat or cure diseases using the body’s cells, have been on the ascendant for some time now. As promising as they are, CGTs have consistently moved forward faster than regulatory agencies can...

2 months ago
Clinical Development,Clinical Operations,News

Solving Regulatory Issues in Cell and Gene Therapies

Cell and Gene Therapies (CGTs), experimental technologies to treat or cure diseases using the body’s cells, have been on the ascendant for some time now. As promising as they are, CGTs have consistently moved forward faster than regulatory agencies can...

2 months ago
Working With us

Interested?
Reserve your space